UniProt ID | CBX8_HUMAN | |
---|---|---|
UniProt AC | Q9HC52 | |
Protein Name | Chromobox protein homolog 8 | |
Gene Name | CBX8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 389 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility.. | |
Protein Sequence | MELSAVGERVFAAEALLKRRIRKGRMEYLVKWKGWSQKYSTWEPEENILDARLLAAFEEREREMELYGPKKRGPKPKTFLLKAQAKAKAKTYEFRSDSARGIRIPYPGRSPQDLASTSRAREGLRNMGLSPPASSTSTSSTCRAEAPRDRDRDRDRDRERDRERERERERERERERERERGTSRVDDKPSSPGDSSKKRGPKPRKELPDPSQRPLGEPSAGLGEYLKGRKLDDTPSGAGKFPAGHSVIQLARRQDSDLVQCGVTSPSSAEATGKLAVDTFPARVIKHRAAFLEAKGQGALDPNGTRVRHGSGPPSSGGGLYRDMGAQGGRPSLIARIPVARILGDPEEESWSPSLTNLEKVVVTDVTSNFLTVTIKESNTDQGFFKEKR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MELSAVGE -------CCCCHHHH | 12.03 | - | |
4 | Phosphorylation | ----MELSAVGERVF ----CCCCHHHHHHH | 13.96 | 19007248 | |
28 | Phosphorylation | IRKGRMEYLVKWKGW HHHCCHHHHEEECCC | 13.88 | 20860994 | |
33 | Ubiquitination | MEYLVKWKGWSQKYS HHHHEEECCCCCCCC | 44.80 | 29967540 | |
67 | Phosphorylation | REREMELYGPKKRGP HHHHHHHHCCCCCCC | 20.34 | 29496907 | |
70 | Ubiquitination | EMELYGPKKRGPKPK HHHHHCCCCCCCCCC | 51.22 | 29967540 | |
92 | Phosphorylation | AKAKAKTYEFRSDSA HHHHCCEEEECCCCC | 16.62 | 29496907 | |
96 | Phosphorylation | AKTYEFRSDSARGIR CCEEEECCCCCCCCC | 41.04 | 28555341 | |
106 | Phosphorylation | ARGIRIPYPGRSPQD CCCCCCCCCCCCHHH | 18.89 | 28102081 | |
110 | Phosphorylation | RIPYPGRSPQDLAST CCCCCCCCHHHHHHH | 32.59 | 29255136 | |
116 | Phosphorylation | RSPQDLASTSRAREG CCHHHHHHHHHHHHH | 33.92 | 28102081 | |
117 | Phosphorylation | SPQDLASTSRAREGL CHHHHHHHHHHHHHH | 19.34 | 24732914 | |
118 | Phosphorylation | PQDLASTSRAREGLR HHHHHHHHHHHHHHH | 22.80 | 24732914 | |
130 | Phosphorylation | GLRNMGLSPPASSTS HHHHCCCCCCCCCCC | 24.10 | 25159151 | |
134 | Phosphorylation | MGLSPPASSTSTSST CCCCCCCCCCCCCCC | 39.66 | 30243723 | |
135 | Phosphorylation | GLSPPASSTSTSSTC CCCCCCCCCCCCCCC | 28.60 | 24732914 | |
136 | Phosphorylation | LSPPASSTSTSSTCR CCCCCCCCCCCCCCC | 33.26 | 24732914 | |
137 | Phosphorylation | SPPASSTSTSSTCRA CCCCCCCCCCCCCCC | 28.39 | 24732914 | |
138 | Phosphorylation | PPASSTSTSSTCRAE CCCCCCCCCCCCCCC | 27.13 | 24732914 | |
139 | Phosphorylation | PASSTSTSSTCRAEA CCCCCCCCCCCCCCC | 24.34 | 29396449 | |
140 | Phosphorylation | ASSTSTSSTCRAEAP CCCCCCCCCCCCCCC | 31.45 | 29396449 | |
141 | Phosphorylation | SSTSTSSTCRAEAPR CCCCCCCCCCCCCCC | 13.04 | 29396449 | |
188 | Acetylation | GTSRVDDKPSSPGDS CCCCCCCCCCCCCCC | 42.19 | 26051181 | |
190 | Phosphorylation | SRVDDKPSSPGDSSK CCCCCCCCCCCCCCC | 55.71 | 29255136 | |
191 | Phosphorylation | RVDDKPSSPGDSSKK CCCCCCCCCCCCCCC | 41.24 | 29255136 | |
195 | Phosphorylation | KPSSPGDSSKKRGPK CCCCCCCCCCCCCCC | 50.39 | 22167270 | |
196 | Phosphorylation | PSSPGDSSKKRGPKP CCCCCCCCCCCCCCC | 47.11 | 22167270 | |
198 | Ubiquitination | SPGDSSKKRGPKPRK CCCCCCCCCCCCCCC | 65.62 | 24816145 | |
205 | Ubiquitination | KRGPKPRKELPDPSQ CCCCCCCCCCCCCCC | 72.61 | 29967540 | |
205 | Acetylation | KRGPKPRKELPDPSQ CCCCCCCCCCCCCCC | 72.61 | 26051181 | |
227 | Ubiquitination | AGLGEYLKGRKLDDT CCHHHHHCCCCCCCC | 56.63 | 29967540 | |
234 | Phosphorylation | KGRKLDDTPSGAGKF CCCCCCCCCCCCCCC | 21.01 | 25159151 | |
236 | Phosphorylation | RKLDDTPSGAGKFPA CCCCCCCCCCCCCCC | 43.28 | 24732914 | |
240 | Acetylation | DTPSGAGKFPAGHSV CCCCCCCCCCCCCHH | 47.87 | 23749302 | |
246 | Phosphorylation | GKFPAGHSVIQLARR CCCCCCCHHHHHHHH | 21.72 | 24732914 | |
256 | Phosphorylation | QLARRQDSDLVQCGV HHHHHCCCCCEECCC | 25.22 | 23927012 | |
264 | Phosphorylation | DLVQCGVTSPSSAEA CCEECCCCCCCHHHH | 21.87 | 30266825 | |
265 | Phosphorylation | LVQCGVTSPSSAEAT CEECCCCCCCHHHHC | 22.00 | 23927012 | |
267 | Phosphorylation | QCGVTSPSSAEATGK ECCCCCCCHHHHCCC | 41.78 | 30266825 | |
268 | Phosphorylation | CGVTSPSSAEATGKL CCCCCCCHHHHCCCE | 33.25 | 30278072 | |
272 | Phosphorylation | SPSSAEATGKLAVDT CCCHHHHCCCEEHHC | 26.76 | 23927012 | |
274 | Acetylation | SSAEATGKLAVDTFP CHHHHCCCEEHHCCC | 28.99 | 26051181 | |
279 | Phosphorylation | TGKLAVDTFPARVIK CCCEEHHCCCHHHHH | 25.56 | 28555341 | |
295 | Ubiquitination | RAAFLEAKGQGALDP HHHHHHHCCCCCCCC | 42.25 | - | |
305 | Phosphorylation | GALDPNGTRVRHGSG CCCCCCCCEEECCCC | 32.41 | - | |
311 | Phosphorylation | GTRVRHGSGPPSSGG CCEEECCCCCCCCCC | 41.84 | 23927012 | |
315 | Phosphorylation | RHGSGPPSSGGGLYR ECCCCCCCCCCCCCC | 44.76 | 30266825 | |
316 | Phosphorylation | HGSGPPSSGGGLYRD CCCCCCCCCCCCCCC | 47.43 | 23403867 | |
321 | Phosphorylation | PSSGGGLYRDMGAQG CCCCCCCCCCCCCCC | 14.08 | 23403867 | |
324 | Sulfoxidation | GGGLYRDMGAQGGRP CCCCCCCCCCCCCCC | 3.38 | 21406390 | |
332 | Phosphorylation | GAQGGRPSLIARIPV CCCCCCCHHEEECCC | 30.92 | 25159151 | |
350 | Phosphorylation | LGDPEEESWSPSLTN HCCCCCCCCCCCCCC | 35.81 | 20068231 | |
352 | Phosphorylation | DPEEESWSPSLTNLE CCCCCCCCCCCCCCE | 17.56 | 25159151 | |
354 | Phosphorylation | EEESWSPSLTNLEKV CCCCCCCCCCCCEEE | 42.16 | 28102081 | |
356 | Phosphorylation | ESWSPSLTNLEKVVV CCCCCCCCCCEEEEE | 41.94 | 30576142 | |
386 | Ubiquitination | NTDQGFFKEKR---- CCCCCCCCCCC---- | 61.13 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CBX8_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CBX8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CBX8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 AND SER-110,ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110; SER-256 ANDSER-311, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110; SER-130; SER-256;SER-265; SER-332 AND SER-352, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110 AND SER-265, ANDMASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 AND SER-110,ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. |